CANCER PROGRAM ANNUAL REPORT 1996-1997

9/23/97

Author: Vencine Kelly

 

Table of Contents

CANCER PROGRAM ANNUAL REPORT 1996-1997

The Cancer Data Base at University Hospital

Stony Brook University Medical Center Tumor Registry

INCIDENCE TRENDS

High Incidence Cancer Sites

1996 Cancer Site Table

1996 CANCER PATIENTS GENDER DISTRIBUTION

1996 Cancer Patient Age Distribution

1996 EthnicityDistribution

Percent of Patients with Pathologic AJCC TNM Stage at Initial Diagnosis in 1996

Breast Cancer

FOCUS ON BREAST CANCER

1996 Breast Cancer Histology

Breast Cancer Age Group at Diagnosis 289 Patients in 1996 at University Hospital vs. National Cancer Data Base

Breast Cancer pAJCC TNM Stage at Diagnosis University Hospital vs.National Cancer Data Base

Breast Cancer First Course of Treatment by AJCC TNM Stage 289 Patients at Stony Brook University Medical Center in 1996

Breast Cancer Overall Survival 1990 University Hospital and 1986-87 National Cancer Data Base Cases Percent of all AJCC TNM stage patients surviving over 5 years

Breast Care Center Stony Brook University Medical Center Increased Patient Visits

Breast Cancer Operations at Stony Brook University Medical Center

Breast Cancer Foundation

Cancer Patient Follow-up Registry at Stony Brook University Medical Center 1984 to 1997

Lifetime Patient Follow-up Surveillance

 

    University Hospital
    Stony Brook New York
    Cancer Statistics

 

  • A total of 15,618 cases have been accessioned in the Tumor Registry data base from 1984-1996, with numbers trending upwards, as demonstrated in the 1990 to 1996 data.
  • 1996=1,807
  • 1995=1,811
  • 1994=1,608
  • 1993=1,355
  • 1992=1,309
  • 1991=1,070
  • 1990=1,038
  • The three most frequently seen sites at University Hospital from 1984 to 1996 account for 39% of the accessioned Tumor Registry cases.
  • Breast = 2,624
  • Prostate = 1,527
  • Lung = 1,881

 

  • The Stony Brook University Medical Center Tumor Registry database has been in operation from 1984 to today. It has proved to be a valuable component of the hospital's Commission on Cancer Approved Program since 1987.
  • Information on cancer site, stage, histology, treatment, survival and epidemiologic characteristics is maintained in accordance with quality and confidentiality standards. This valuable information is managed by Certified Tumor Registrars and is provided to our researchers, administrators and clinicians to assist in research, grant writing, administrative planning and clinical outcome measurement activities.
  • Requests for data are responded to promptly by contacting the Tumor Registry at 444-1301
  • Contact our web site at http//uhmc.sunysb.edu/cancerhot/cancer.

 

  • Data shows an increasing trend in 1990-1996 cancer case accessions.
  • Analytic includes patients first diagnosed here, and patients who received all or part of their first course of treatment here.
  • Non-analytic are patients first seen here for recurrence or progression in the year of accession.

 

      Tumor Registry Data Base Accessions from 1984 to 1996 Equals 15,618 Cases

 

  • A total of 1,807 cases were accessioned into the Tumor Registry at Stony Brook University Medical Center in 1996.
  • 1,525 were newly diagnosed and received all or part of initial therapy here.
  • 282 presented here with recurrence or progression.

 

      = 996

      = 881

 

  • Age Group Number of Patients
  • 0-19 38
  • 20-29 45
  • 30-39 111
  • 40-49 220
  • 50-59 403
  • 60-69 460
  • 70-79 385
  • 80+ 145

          1,807 Total Cancer Sites at University Hospital in 1996

 

  • Caucasion, NOS
  • Caucasian Hispanic
  • Black
  • Asian
  • Other
  • 92.2%
  • 2.9%
  • 4.4%
  • 0.3%
  • 0.3%

          1,807 Total Cancer Sites at University Hospital in 1996

 

    A Site Specific Survey of 289 Newly Diagnosed Patients First Seen in 1996
    at University Hospital
    Stony Brook, New York


  • Our tumor registry survey of 289 breast cancer cases diagnosed in 1996 demonstrates ductal carcinoma as the most often seen pathology
  • Initial therapy may be multimodality, including surgery, radiation therapy and chemotherapy, as appropriate to stage and other factors.
  • Statistical comparison with national data shows patients here diagnosed at an earlier stage and at younger age than national cancer data base averages.
  • Overall 5-year survival for all stages compares favorably with National Cancer Data Base statistics.

  • b1

  • In 1990, Carol M. Baldwin was diagnosed with breast cancer. Her experience led to her taking a leadership role in raising funds for breast cancer research. In 1996 the Carol m Baldwin Breast Cancer Research Fund, Inc. was formed as a sole purpose corporation to raise money for breast cancer research at University Hospital and Medical Center at Stony Brook, one of the nation's three top public research institutions and a major Long Island resource.
  • Carol has been joined in this effort by her children - daughters Jane and Elizabeth; and her sons - actors Alec, Stephen, Billy and Daniel.
  • To donate, please contact Carol M. Baldwin Breast Cancer Research Fund, Inc. at 516- 444-2919 or send your donations to PO Box 600, Stony Brook, NY 11790, make checks payable to Carol M. Baldwin Breast Cancer Research Fund, Inc.

     

back button